Scope Fluidics Spolka Akcyjna has a quick ratio of 11.23. It generally indicates good short-term financial strength.
The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's Quick Ratio or its related term are showing as below:
FRA:S84'
s Quick Ratio Range Over the Past 10 Years
Min: 1.59 Med: 10.5 Max: 67.91
Current: 11.23
During the past 10 years, Scope Fluidics Spolka Akcyjna's highest Quick Ratio was 67.91. The lowest was 1.59. And the median was 10.50.
FRA:S84's Quick Ratio is ranked better than 96.26% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.69
vs FRA:S84: 11.23
Scope Fluidics Spolka Akcyjna (FRA:S84) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Scope Fluidics Spolka Akcyjna Quick Ratio Related Terms
Scope Fluidics Spolka Akcyjna Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scope Fluidics Spolka Akcyjna Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Quick Ratio falls into.
Scope Fluidics Spolka Akcyjna Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scope Fluidics Spolka Akcyjna (FRA:S84) has a Quick Ratio of 11.23 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. This is near median its historical median of 10.50. Over the past decade, Scope Fluidics Spolka Akcyjna's Quick Ratio has ranged from 1.59 to 67.91. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #8 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 3.7%.
Is Scope Fluidics Spolka Akcyjna's Quick Ratio too high?
Scope Fluidics Spolka Akcyjna's current Quick Ratio of 11.23 is near median its 10-year median of 10.50. Over the past 10 years, this metric has ranged from a low of 1.59 to a high of 67.91. The Medical Diagnostics & Research industry median Quick Ratio is 1.69. Scope Fluidics Spolka Akcyjna's value of 11.23 is 564.5% above this industry median. Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #8 out of 214 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Quick Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #8 out of 214 companies for Quick Ratio. This places Scope Fluidics Spolka Akcyjna in the top 4% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.69. Scope Fluidics Spolka Akcyjna's value of 11.23 is 564.5% above this benchmark. Historically, Scope Fluidics Spolka Akcyjna's own Quick Ratio has ranged from 1.59 to 67.91 over the past decade. While the company's 10-year median is 10.50 vs. the industry median of 1.69, Scope Fluidics Spolka Akcyjna has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.69, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scope Fluidics Spolka Akcyjna's current Quick Ratio of 11.23 is 564.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scope Fluidics Spolka Akcyjna's current Quick Ratio is 11.23, which is near median its own 10-year median of 10.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current Quick Ratio of 11.23. The stock's GF Value™ is €26.71, compared to a current price of €24.00 — trading 10.1% below its estimated fair value. The current Quick Ratio is 11.23, which is near median its 10-year median of 10.50 and 564.5% above the Medical Diagnostics & Research industry median of 1.69. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current Quick Ratio is 11.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued.
The current stock price of €24.00 is trading 10.1% below its estimated GF Value™ of €26.71.
Key valuation signals for FRA:S84:
Quick Ratio: 11.23 (near median its 10-year median of 10.50)
GF Value™: €26.71 vs. price of €24.00 (10.1% below fair value)
Industry Position: 564.5% above the Medical Diagnostics & Research median (#8 of 214)
No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scope Fluidics Spolka Akcyjna Business Description
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
44GF Score
Get the complete analysis for FRA:S84
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S84 has been successfully added to your 
